Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Troussard

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Leukemia|November 20, 2019
BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trialsNora Liebers, Tobias Roider, Jan-Paul Bohn, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2025
Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based studyAnnalisa Trama, Silvia Rossi, Damien Bennet, et al.
Pediatric Hematology and Oncology|February 1, 2013
Cancer incidence and survival in adolescents and young adults in France, 2000-2008Emmanuel Desandes, Brigitte Lacour, Aurélien Belot, et al.
Leukemia & Lymphoma|February 3, 2015
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphomaCédric Rossi, Jérémie Jégu, Morgane Mounier, et al.
Annals of Epidemiology|March 19, 2018
Use of a case-mix approach to study the trends in the incidence of second primary cancersBoris Gass, Emilie Marrer, Simona Bara, et al.
Haematologica|July 18, 2015
Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC networkGandhi Damaj, Sarah Ivanoff, Diane Coso, et al.
Cancer Epidemiology|February 12, 2021
What is the most appropriate period to define synchronous cancers?Florent Baicry, Florence Molinié, Sandrine Plouvier, et al.
British Journal of Haematology|April 23, 2014
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemiaEdouard Cornet, Cécile Tomowiak, Aline Tanguy-Schmidt, et al.
British Journal of Haematology|April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 studyEmanuele Crocetti, Damien Bennett, Valérie Jooste, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Leukemia|November 20, 2019
BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trialsNora Liebers, Tobias Roider, Jan-Paul Bohn, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2025
Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based studyAnnalisa Trama, Silvia Rossi, Damien Bennet, et al.
Pediatric Hematology and Oncology|February 1, 2013
Cancer incidence and survival in adolescents and young adults in France, 2000-2008Emmanuel Desandes, Brigitte Lacour, Aurélien Belot, et al.
Leukemia & Lymphoma|February 3, 2015
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphomaCédric Rossi, Jérémie Jégu, Morgane Mounier, et al.
Annals of Epidemiology|March 19, 2018
Use of a case-mix approach to study the trends in the incidence of second primary cancersBoris Gass, Emilie Marrer, Simona Bara, et al.
Haematologica|July 18, 2015
Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC networkGandhi Damaj, Sarah Ivanoff, Diane Coso, et al.
Cancer Epidemiology|February 12, 2021
What is the most appropriate period to define synchronous cancers?Florent Baicry, Florence Molinié, Sandrine Plouvier, et al.
British Journal of Haematology|April 23, 2014
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemiaEdouard Cornet, Cécile Tomowiak, Aline Tanguy-Schmidt, et al.
British Journal of Haematology|April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 studyEmanuele Crocetti, Damien Bennett, Valérie Jooste, et al.
Pageof 16